Update on Glaxo’s Contracts


GlaxoSmithKline (GSK) has several contracts in its kitty to supply products including antibiotics, cephalosporins and penicillins to contract manufacturing partners. The Biomedical Advanced Research and Development Authority (BARDA), a part of the U.S. Department of Health and Human Services (HHS), has entered into a four-year contract with Glaxo to purchase raxibacumab for combating a potential bioterrorist attack.

Read the source article at Zacks Investment Research